| Code | 4800D | ||||||||||
| MA number | 44/0137/20-S | ||||||||||
| Product Form: | cps dur 7x1x12,5 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.06.2020 |
| Validity: | 19.06.2025 |
| SPC: |
SPC_Sunitinib FMK 12,5 mg tvrdé kapsuly_10.2023.pdf
|
| PIL: |
PIL_Sunitinib FMK 12,5 mg tvrdé kapsuly_10.2023.pdf
|
| Safety feature | Yes |
| Data update: | 17.10.2023 |
